cinj.org
Jan 26, 2025, 11:59
Safety and cCR of Chemoradiation with OBP-301 in Inoperable Esophageal Cancer
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared on X:
“NRG GI-007
LA-Esophagus Carcinoma
dCRT (50.4 Gy/28 fx carbo/taxol) + endoscopically injected oncolytic virus OBP-301
cCR rate
Comparatively favorable AE profile
Brilliant work and looking forward to future study!!”
Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 09:26
Sep 4, 2025, 08:36
Sep 4, 2025, 08:36
Sep 4, 2025, 08:27
Sep 4, 2025, 08:13